Detalles de la búsqueda
1.
[Therapeutic effect of mycophenolate mofetil or cyclophosphamide in children with Henoch-Schönlein purpura nephritis of different age groups]. / ä¸åå¹´é¾æ®µè¿ææ§ç´«çæ§è¾çæ£å¿æ¥åéé é ¸é ¯æç¯ç£·é °èºæ²»çççæå·®å¼åæ.
Zhongguo Dang Dai Er Ke Za Zhi
; 25(11): 1113-1117, 2023 Nov 15.
Artículo
en Zh
| MEDLINE | ID: mdl-37990454
2.
Clinical effect of different prednisone regimens in the treatment of children with primary nephrotic syndrome and risk factors for recurrence. / ä¸åæ¹æ¡æ³¼å°¼æ¾æ²»çå¿ç«¥ååæ§è¾ç 综åå¾ççæåå¤åå±é©å ç´ åæ.
Zhongguo Dang Dai Er Ke Za Zhi
; 24(8): 853-857, 2022 Aug 15.
Artículo
en Inglés, Zh
| MEDLINE | ID: mdl-36036121
3.
[Efficacy and safety of mycophenolate mofetil versus cyclophosphamide in the treatment of Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria in children: a prospective randomized controlled trial].
Zhongguo Dang Dai Er Ke Za Zhi
; 23(4): 338-342, 2021 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-33840404
4.
[A prospective, randomized, controlled clinical study of Huai Qi Huang granules in treatment of childhood primary nephrotic syndrome].
Zhongguo Dang Dai Er Ke Za Zhi
; 17(1): 31-4, 2015 Jan.
Artículo
en Zh
| MEDLINE | ID: mdl-25616289
Resultados
1 -
4
de 4
1
Próxima >
>>